Home / Companies / Lyra Therapeutics, Inc. / 14 May 2025
Lyra Therapeutics, Inc.: meeting of 14 May 2025
Votes reported on Form N-PX, item by item
22 Form N-PX filers reported votes at the Lyra Therapeutics, Inc. meeting of 14 May 2025. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 72.0% of reported votes for; 14 filers withheld from or voted against at least one nominee.
82 vote records from 22 filers. 1 of the 22 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
41 vote records from 22 filers. 0 of the 22 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
41 vote records from 22 filers. 0 of the 22 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
41 vote records from 22 filers. 2 of the 22 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| ProShares and ProFunds | Split or no vote | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For |
| Goldman Sachs | Split or no vote | For |
| T. Rowe Price | Split or no vote | For |
| Lincoln Financial | Split or no vote | For |
| Guggenheim and Rydex | Split or no vote | For |
| Columbia Threadneedle | For | For |
| Global X | For | For |
| DWS | Split or no vote | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Lyra Therapeutics, Inc. meeting?
22 Form N-PX filers reported votes at the meeting of 14 May 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Lyra Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Lyra Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Lyra Therapeutics, Inc. with a meeting date within three days of 14 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.